Odivu kattum pasai for Padangaal enbu murivu

An open single arm clinical trial to determine the therapeutic effectiveness of odivu kattum pasai in the treatment of padangaal enbu murivu (meta tarsal fracture) - OKP-odivu kattum pasai

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066774

Enrollment

Registered

2024-05-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M843- Stress fracture

Interventions

Intervention1: Odivu kattum pasai for Padangaal enbu murivu: Dose:Sufficient quantity Frequency:3 days once Duration:48 days external application Intervention2: Odivu kattum pasai for Padangaal enbu m

Eligibility

Inclusion criteria

Inclusion criteria: Patient reporting with history of Meta tarsal fracture within 15 days of trauma Patients willing to undergo radiological investigation Patient willing to sign the informed consent stating that he/she will consciously stick to the treatment but can opt out of the trial of his/her own conscious discretion

Exclusion criteria

Exclusion criteria: Open fracture Comminuted fracture Foot ulcers Fracture with malunion Un Controlled Diabetes Mellitus K/H/O Hypertension K/H/O Peripheral Neuritis

Design outcomes

Primary

Measure	Time frame
To determine the therapeutic effectiveness of odivu kattum pasai in the treatment of Padangaal enbu murivu (Meta tarsal fracture) and assess the prognosis of padangaal enbu murivu (Meta tarsal fracture) through AOFAS scale Timepoint: 48 days	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactM V Mahadevan

National institute of siddha

puramaruthuvam@gmai.com9840417565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026